ReproCELL Incorporated (FRA:6RC)

Market Cap	76.73M
Revenue (ttm)	15.16M
Net Income (ttm)	-1.61M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.6150
Previous Close	0.5950
Day's Range	0.6150 - 0.6150
52-Week Range	0.3660 - 1.3800
Beta	n/a
RSI	46.30
Earnings Date	Feb 12, 2026

About ReproCELL

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, StemEdit gene edited iPSCs, mesenchymal stem cells (MSCs), and new immortalized cell lines and related reagents; and iPSC-...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2003
• Employees: 99
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 6RC

Financial Performance

Financial numbers in JPY